Insiders NexImmune, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:30:00 2024-06-13 pm EDT			5-day change	1st Jan Change
2.9 ^USD	+0.35%		-9.38%	+30.63%

May. 20	NexImmune, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Apr. 17	North American Morning Briefing : Stock Futures -2-	DJ

NexImmune, Inc. Announces Executive Changes	Apr. 05	CI
NexImmune Cutting Over Half of Workforce to Fund Development of Novel Therapeutic Candidates	23-08-31	MT
NexImmune, Inc. Announces Executive Changes, Effective as of September 2, 2023	23-08-31	CI
Insider Buy: Neximmune	23-03-31	MT
NexImmune Inc. Appoints Leena Gandhi to Board of Directors as a Non-Executive Director	22-05-10	CI
NexImmune Appoints Mathias Oelke Chief Scientific Officer	22-04-14	MT
Neximmune, Inc. Promotes Mathias Oelke, Ph.D., to Chief Scientific Officer	22-04-14	CI
Insider Buy: NexImmune	22-03-28	MT
NexImmune, Inc. Announces Management Changes	22-02-17	CI
NexImmune, Inc. Announces Executive Changes	22-02-17	CI
NexImmune, Inc. Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board	22-01-05	CI
NexImmune, Inc. Announces Executive Appointments	21-11-12	CI
NexImmune, Inc. Announces Executive Appointments	21-07-14	CI
NexImmune, Inc. Announces Formation of Scientific Advisory Board	21-05-27	CI
NexImmune, Inc. Appoints Chad Rubin as Senior Vice President, Corporate Affairs	21-04-21	CI
NexImmune Appoints Grant Verstandig as New Board Member	21-01-19	CI
Neximmune Names Robert Knight as Chief Medical Officer	21-01-18	CI
Neximmune Announces Executive Changes	21-01-04	CI
NexImmune, Inc. Announces Executive Appointments	20-01-09	CI
NexImmune Appoints Sol Barer as Chairman of the Board of Directors	19-12-16	CI

No results for this search